Related Experiment Video
Updated: Feb 25, 2026
12:58
A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
Published on: May 25, 2017
9.4K
Nonantimicrobial drug targets for Clostridium difficile infections
Charles Darkoh1,2, Magdalena Deaton1, Herbert L DuPont1,3
1Department of Epidemiology, Human Genetics, & Environmental Sciences, Center For Infectious Diseases, School of Public Health, University of Texas Health Science Center, Houston, TX 77030, USA.
Future Microbiology
|August 1, 2017
Summary
Clostridium difficile infection (CDI) presents a global health challenge. Nonantibiotic strategies targeting toxins, colonization, and microbiota restoration offer promising new treatments for CDI.
Area of Science:
- Microbiology
- Infectious Diseases
- Gastroenterology
Background:
- Clostridium difficile infection (CDI) is a significant global health concern.
- Increasing antibiotic resistance and virulent strains complicate CDI treatment.
- Disruption of gut microbiota by antibiotics compromises colonization resistance, increasing CDI risk.
Purpose of the Study:
- To identify and outline critical nonantibiotic therapeutic targets for combating CDI.
- To explore strategies for developing future nonantibiotic agents against CDI.
Main Methods:
- Review of current literature on CDI pathogenesis and treatment limitations.
- Identification of key bacterial factors and host-pathogen interactions in CDI.
- Analysis of potential nonantibiotic therapeutic approaches.
Main Results:
- Nonantibiotic strategies focus on inhibiting toxins, colonization factors, and virulence.
- Restoration of gut microbiota is a key target for enhancing colonization resistance.
- Disrupting pathogen persistence and reducing toxin exposure are crucial.
Conclusions:
- Targeting colonization and virulence factors offers a viable nonantibiotic approach to CDI.
- Future therapies should aim to inhibit CDI virulence and restore gut microbiota balance.
- Nonantibiotic treatments are essential for managing the growing threat of CDI.
Related Concept Videos
01:26Targets for Drug Action: Overview
10.8K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
10.8K
01:18Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
506
Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
506
01:27Combined Effects of Drugs: Synergism
7.0K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
7.0K
01:23Antimicrobial Proteins
14.8K
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
14.8K
01:30Development of Antibiotic Resistance
1.7K
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
1.7K
01:28Gene Regulation in Microbial Communities: Quorum Sensing
762
Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
762